Back to mobile site

Penwest Pharma (PPCO, Endo Pharma (ENDP) Grant Valeant (VRX) Exclusive License to Market Opana(r) ER in Canada, Australia and New Zealand

June 9, 2009 8:38 AM EDT Send to a Friend
Penwest Pharmaceuticals Co. (Nasdaq: PPCO), Endo Pharmaceuticals (Nasdaq: ENDP) and Valeant Pharmaceuticals (NYSE: VRX) today announced that Endo has signed ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login